Physician profile
Sahitya Denduluri
NPI 1114381373
$23,851.65
in general payments reported to CMS, 2019-2025
13 companies · $850 in 2025
The $850 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,368 · 2020: $1,672 · 2021: $16K · 2022: $1,881 · 2023: $418 · 2024: $801 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.91 |
| Travel and Lodging | $544.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $10,743.16 | 2021-2025 | Acumed, Innate Implant, Acumed |
| Evolution Surgical, INC | $7,640.44 | 2019-2021 | |
| Axogen | $1,727.78 | 2021-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Peerless Surgical INC. | $1,230.89 | 2022 | |
| Skeletal Dynamics INC | $1,064.20 | 2022-2025 | Geminus, Ijs, Implate |
| Stryker Corporation | $446.58 | 2021-2024 | Conextions Tr Tendon Repair System-Implant Mechanism |
| Checkpoint Surgical, INC | $295.19 | 2023-2025 | Checkpoint Stimulators |
| Depuy Synthes Sales INC. | $239.50 | 2021-2025 | Na |
| Endo Pharmaceuticals INC. | $126.39 | 2022 | |
| Osteomed LLC | $121.83 | 2021 | |
| Zimmer Biomet Holdings, INC. | $116.09 | 2021 | |
| Sonex Health, INC. | $78.19 | 2022-2025 | Sx-One Microknife |
| Trimed, INC. | $21.41 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sahitya Denduluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.